Bayer Articles
Stock Commentary - Europe - week to June 16, 2008
23 June 2008
Stock Commentary - Europe - week to June 9, 2008
16 June 2008
Bayer reports strong results in Leukine trial
16 June 2008
Rivaroxaban beats Lovenox: RECORD4 trial
16 June 2008
Belgian drug group hits out over DTC claims
16 June 2008
IBA buys 80% of CIS bio from IRE
9 June 2008
Stock Commentary - Europe - week to June 2, 2008
9 June 2008
Strong mid-stage data on Nexavar
9 June 2008
Bayer's Xarelto wins out in study
9 June 2008
Correction: Novartis' Extavia
9 June 2008
Stock Commentary - New York week to May 26, 2008
2 June 2008
Bayer Vital settles law suit
2 June 2008
Bayer seeks Polish acquisitions
2 June 2008
Approval for Novartis' generic Betaferon in EU
2 June 2008
Greater lung exposure for inhaler than IV
2 June 2008
MS drug pipeline update from Bayer Schering
26 May 2008
First CV polypill to enter US clinical testing
26 May 2008
Bayer debuts reformulated Leukine in USA
26 May 2008
Strong data for Bayer's Avelox in CAP
26 May 2008
Nexavar improves overall survival 47.3%
26 May 2008
Bayer Schering debuts MS awareness initiative
26 May 2008
Bayer pulls remaining stocks of Trasylol
19 May 2008
Stock Commentary - Europe - week to May 12, 2008
19 May 2008
ZymoGenetics' 1st-qtr loss widens 22.8%
19 May 2008
VEGF Trap-Eye enters Ph III testing
19 May 2008
Onyx shatters expectations in 1st qtr
19 May 2008
Stock Commentary - Europe - week to May 5, 2008
12 May 2008
Bayer Schering to market Yaz in EU
12 May 2008
VEGF Trap maintains gain in visual acuity
12 May 2008
EC extends label for Bayer HealthCare
5 May 2008
Titan presents follow-up Spheramine data
5 May 2008
Nexavar excluded from Japan's DPC
5 May 2008
Stock Commentary - Europe - week to April 21, 2008
28 April 2008
Lilly has good 1Q sales but still disappoints
28 April 2008
Maryland OKs Medicaid reimbursement for ActiPatch
28 April 2008
Sweden's BioInvent falls into loss
21 April 2008
Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit jumps 4.8% to $2.8M
14 April 2008
Japan stock market week to April 7, 2008
14 April 2008
EFPIA wants "less freedom" from EC
14 April 2008
M&A updates: Pfizer/Encysive; Bayer /Possis
7 April 2008
Europe's IMI announces launch of 2008 priorities
7 April 2008
UK Pom to P switch for Bayer's naproxen
7 April 2008
EC approves Boeh Ing's Pradaxa in VTE
7 April 2008
Levitra helps ED patients with high cholesterol
31 March 2008
CHMP recommends expanded label for Zevalin
31 March 2008
EPIX discontinues MDD drug on poor efficacy
31 March 2008
11 defendants settle US AWP litigation
24 March 2008
Stock Commentary - Europe - week to March 17, 2008
24 March 2008
Stock Commentary - New York week to March 10, 2008
17 March 2008
Stock Commentary - Europe - week to March 10, 2008
17 March 2008
Bayer to launch RFID-based radiology management system
17 March 2008
Review study suggests NSAIDs, including aspirin, may cut risk of developing breast cancer 20%
17 March 2008
Stock Commentary - Europe - week to March 3, 2008
10 March 2008
US court rules patent for Yasmin is invalid
10 March 2008
New Rebif formulation launched in UK
10 March 2008
Everolimus trial halted after early PFS gains
10 March 2008
Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations
10 March 2008
Ipsen's 2007 operating profit climbs 12%
10 March 2008
Stock Commentary - Europe - week to Feb 25, 2008
3 March 2008
2007 Bayer's most successful year to date
3 March 2008
US Pres promises $350M for neglected diseases
3 March 2008
Patient adherence event preview
3 March 2008
Onyx narrows 4th-qtr 2007 loss to $11.7M
3 March 2008
Millipore in technology deal with Bayer
3 March 2008
US Pres promises $350M for neglected diseases
3 March 2008
Stock Commentary - Europe - week to Feb 18, 2008
25 February 2008
UPDATE: Bayer and Onyx halt Nexavar trial in NSCLC
25 February 2008
US law suits filed over Trasylol kidney AEs
25 February 2008
Bayer/Onyx halt Nexavar trial in NSCLC
25 February 2008
Medrad to acquire Possis for $361M
18 February 2008
Stock Commentary - Europe - week to Feb 11, 2008
18 February 2008
Study finds Tasylol safe in certain surgeries
18 February 2008
Salsalate lowers inflammation in obese patients
11 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
EC clears Angiox for ACS with UA or NSTEMI
4 February 2008
IFPMA increases assistance to WHO-based TDR program
4 February 2008
Clexane, and Nexavar in RCC approved in Japan
4 February 2008
Xanthus' oral fludarabine NDA accepted by FDA
4 February 2008
FDA OKs Banner's nimodipine caps
4 February 2008
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
